Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Published on by Book of Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Prof. Dr. Wu Zhonglan | Medicine and Dentistry | Best Researcher Award

Ningxia Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid

🌱 Early Academic Pursuits

Prof. Dr. Wu Zhonglan's academic journey is marked by excellence and global engagement. Currently pursuing her PhD in Pathogen and Host Immunology, she laid a strong foundation with earlier distinctions that shaped her scientific career. Her selection for the National Scholarship enabled a year of advanced study at the QIMR Berghofer Medical Research Institute in Australia (2017–2018), reflecting both national confidence and international potential in her research acumen.

💼 Professional Endeavors

Prof. Wu serves as Chief of the Virus Section at the CDC and a Postgraduate Supervisor at Ningxia Medical University, underscoring her pivotal role in both research and mentorship. She holds influential appointments across national committees, including:

  •  ➤ Director, National AIDS Prevention and Control Association

  •  ➤ Member, National AIDS Testing Committee

  •  ➤ Member, National Microbial Sequencing Technical Committee

  •  ➤ Member, Ningxia Immunology Society

  •  ➤ Editorial Board Member, Journal of Phenomics

Her leadership spans laboratory diagnostics, public health strategy, and national policy.

🔬 Contributions and Research Focus

Prof. Wu’s scientific contributions are rooted in two major domains:

🦠 Viral Pathogen Research:
She has been at the forefront of utilizing Next-Generation Sequencing (NGS) technology for viral traceability—particularly for COVID-19 and monkeypox. Her innovative development of rapid screening platforms for unexplained pneumonia pathogens has strengthened epidemic preparedness and public health surveillance.

🧬 AIDS Molecular Epidemiology:
Prof. Wu is a key figure in HIV research in China. Her work involves constructing molecular transmission networks, analyzing HIV drug resistance, and refining HIV-RNA and HIV-DNA diagnostic technologies for improved treatment strategies and epidemiological tracing. She has successfully led 8 major research projects funded by the Natural Science Foundation, returnee innovation grants, and key R&D initiatives in Ningxia.

🏆 Accolades and Recognition

Prof. Wu has garnered widespread acclaim, including:

  •  ➤ National Public Health Leading Talent Program (2024)

  •  ➤ “Advanced Worker” of the Autonomous Region (2025)

  •  ➤ Ningxia Young Top Talent Cultivation Program (2017)

Her team’s achievements have been celebrated with:

  •  ➤ Third Prize for Scientific and Technological Progress (2019, 2023)

  •  ➤ Second Prize and two Third Prizes of the Ningxia Medical Science and Technology Awards

🌍 Impact and Influence

Through her pioneering work in pathogen genomics and HIV epidemiology, Prof. Wu has enhanced both regional and national capacities in disease control. Her influence extends into policy-making, health strategy design, and next-generation diagnostics. She is a role model for women in science, especially in traditionally male-dominated public health and molecular virology sectors.

📚 Legacy and Future Contributions

Prof. Wu has authored over 60 high-impact publications, with 14 SCI-indexed papers—one boasting an impact factor of 11.39. More than 10 papers have earned Outstanding Paper Awards in Ningxia, reflecting her consistent excellence in scientific communication. Looking ahead, Prof. Wu is poised to further shape China’s viral disease research landscape through integrative genomics, real-time diagnostics, and transdisciplinary collaborations. Her legacy will be defined not only by her discoveries but by the generations of researchers she continues to inspire.

Publications

📄  Sequencing of One Unique Recombinant CRF85_BC/CRF01_AE Genome and Two Partial Genomes from Ningxia, China

Authors: Li Y, Pei J, Zhu X, Liu Y, Ma X, Yang D, Wu Z
Journal: Viruses
Year: 2025

📄  HIV-1 Drug Resistance and Genetic Transmission Networks Among Patients with Sexually Transmitted HIV in Ningxia, China

Authors: Pei J, Wu Z, Si B, Ma C, Liu Y, Ma X, Kuai W, Zhang Y, Li Y
Journal: Frontiers in Public Health
Year: 2025

📄  Epidemiological and Spatial Analysis of Newly Diagnosed HIV-1/AIDS Patients Before Antiretroviral Therapy in Ningxia from 2020 to 2021

Authors: Liu Y, Ma X, Pei J, Yang D, Li Y, Zhu X, Wu Z
Journal: PLOS ONE
Year: 2025

📄  Epidemiological and Spatiotemporal Analysis of Elderly HIV-1/AIDS Patients in Ningxia, China, from 2018 to 2023

Authors: Wu Z, Liu Y, Ma X, Li Y, Zhu X, Yang D, Pei J, Li Y
Journal: Scientific Reports
Year: 2025

📄  Molecular Epidemiology of Hepatitis C Infections in Ningxia, China: Genotype, Phylogeny and Mutation Analysis

Authors: Wu Z, Cui L, Zhao W, Yang D, Chen H, Wang R, Wang X, Zhang L, He T
Journal: Virology Journal
Year: 2016

Le Trung Quang | Veterinary Science and Veterinary Medicine | Best Researcher Award

Published on by Book of Award

Dr. Le Trung Quang | Veterinary Science and Veterinary Medicine | Best Researcher Award

Can Tho University | Vietnam

Author profile

Scopus

Orcid

Google Scholar

🔬 Early Academic Pursuits

Dr. Le Trung Quang’s journey into veterinary sciences began with a strong foundation in animal husbandry at Can Tho University, Vietnam, where he earned his Bachelor’s degree (2012–2016). His undergraduate studies covered a diverse range of essential subjects such as clinical diagnosis, animal nutrition, and epidemiology—laying the groundwork for a promising research career. Driven by a thirst for deeper scientific inquiry, he pursued a Master’s in Veterinary Science and Technology (2021–2022) at the prestigious Chulalongkorn University, Thailand, specializing in cancer cell biology, herbal medicine, and immunological techniques like qRT-PCR and Western blotting.

🧑‍⚕️ Professional Endeavors

Since April 2018, Dr. Quang has been affiliated with the Faculty of Veterinary Medicine at Can Tho University, serving first as a practicing veterinarian and later transitioning into a research-centric role. His practical experience diagnosing and treating companion animals has given him valuable clinical insights that now inform his research into zoonotic diseases, oncology, and immunology in animals. His multidisciplinary approach bridges clinical care with cutting-edge research—an asset rare in the field.

📚 Contributions and Research Focus

Dr. Quang’s research spans several crucial domains: animal models for cancer, infectious diseases (canine distemper, lumpy skin disease, IBDV, FPV), and epidemiology of zoonotic and livestock diseases. Notably, his work on the anti-proliferative effects of cannabinoids on pancreatic cancer in animal models has garnered international attention, with high-impact publications in journals like Scientific Reports and Frontiers in Veterinary Science. His studies consistently blend molecular diagnostics, pathology, and immunohistochemistry, making significant contributions to both animal and translational human medicine.

🏅 Accolades and Recognition

With over 16 peer-reviewed publications in international and regional journals, Dr. Quang's work has become a valuable resource for Southeast Asian veterinary and biomedical science communities. He has co-authored several impactful studies in Viruses, Veterinary World, and the Open Veterinary Journal, reflecting the trust and recognition he commands among his peers. His selection as a contributor to multiple collaborative international research projects demonstrates the credibility and relevance of his expertise.

🌱 Impact and Influence

Dr. Quang’s research is not limited to the lab. His findings directly inform public veterinary health policies in the Mekong Delta, an area vulnerable to zoonotic outbreaks and livestock epidemics. His studies on rabies awareness, vaccine efficacy, and disease molecular characterization have empowered regional veterinary practitioners and policymakers. Furthermore, his dual role as a researcher and practicing veterinarian ensures that scientific advances translate swiftly into clinical solutions.

🔮 Legacy and Future Contributions

As a young yet accomplished researcher, Dr. Le Trung Quang is well-positioned to become a leading voice in veterinary oncology and zoonotic disease management. His growing expertise in molecular pathology, combined with his compassionate clinical background, positions him to bridge the gap between research innovation and real-world veterinary applications. His future endeavors are expected to focus on developing novel therapeutic interventions, strengthening disease surveillance networks, and training the next generation of veterinary scientists in Vietnam and beyond.

Publications

📰 Epidemiological, Clinical, and Molecular Insights into Canine Distemper Virus in the Mekong Delta Region of Vietnam

  • Authors: Tien My Van, Dao Thi Anh Tran, Chien Tran Phuoc Nguyen, Giang Truong Huynh, Mong Thi Nhu Luu, Trung Quang Le, Bich Ngoc Tran

  • Journal: Viruses

  • Year: 2025

📰 Epidemiological and Molecular Characteristics of Infectious Bursal Disease Virus Naturally Infected in the Broiler Flocks in the Mekong Delta of Vietnam During 2015 and 2018

  • Authors: Cuong Ngo Phu, Khanh Nguyen Phuc, Dao Tran Thi Anh, Tien Van My, Trung Quang Le, Bich Tran Ngoc

  • Journal: Veterinary Integrative Sciences

  • Year: 2024

📰  Anti-Proliferative and Apoptotic Effect of Cannabinoids on Human Pancreatic Ductal Adenocarcinoma Xenograft in BALB/c Nude Mice Model

  • Authors: Trung Quang Le, Nuntana Meesiripan, Suleeporn Sanggrajang, Nuntakan Suwanpidokkul, Piyaporn Prayakprom, Chatchada Bodhibukkana, Vipada Khaowroongrueng, Kankanit Suriyachan, Somchai Thanasitthichai, Attasit Srisubat, et al.

  • Journal: Scientific Reports

  • Year: 2024

📰  First Molecular Report of Feline Panleukopenia Virus Infection in Diarrheic Cats at Can Tho City, Vietnam

  • Authors: Trung Quang Le, Tu Thi My Dang, Thao Thi Tran, Tien My Van, Bich Tran Ngoc

  • Journal: Veterinary Integrative Sciences

  • Year:  2023

 

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

 

 

 

 

 

Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

Published on by Book of Award

Prof. Izeta Aganovic Musinovic | Immunology and Microbiology | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Izeta Aganovic Musinovic embarked on her academic journey at the Medical School, University of Sarajevo, earning her Medical Doctor degree in 1994. She further delved into Genetics, completing a Master of Science thesis on chromosomal aberrations in populations exposed to ionizing radiation during wartime.

Professional Endeavors

Her career spanned across various roles at the Centers for Human Genetics and the Department of Immunology at the University of Sarajevo, evolving from an Associate to Senior Associate. She pursued a Residency Program in Immunology, culminating in a Doctor of Science in Immunology. Her trajectory included roles as a Senior Assistant Lecturer and Assistant Professor, contributing significantly to the Department of Immunology.

Contributions and Research Focus

Aganovic Musinovic's contributions notably revolved around immunobiological markers in assessing renal function injury in multiple myeloma patients. Her research journey spanned topics encompassing genetics, hematological disorders, and immunology, evident through her thesis work and subsequent teaching roles in Immunology, Hematology, and Nephrology.

Accolades and Recognition

Her academic achievements were evident through the completion of a Doctor of Science in Immunology and a Master's thesis in Genetics, affirming her commitment to advanced research and academia. The recognition of her contributions was reflected in her appointments as Associate and subsequently as Assistant and Associated Professor at the University of Sarajevo.

Impact and Influence

Aganovic Musinovic's influence was pronounced in the field of Immunology, particularly in advancing the understanding of immunobiological markers for renal function assessment in patients with multiple myeloma. Her teaching roles and extensive research endeavors have contributed to shaping the academic landscape in genetics, immunology, and related medical disciplines.

Legacy and Future Contributions

Her legacy lies in her comprehensive exploration of immunological markers and genetic factors impacting renal function in hematological disorders. Aganovic-Musinovic's commitment to academia, coupled with her research focus, lays the groundwork for future advancements in understanding renal function, genetics, and immunology within medical contexts. Her continued dedication is poised to shape the next generation of medical professionals and drive further breakthroughs in the field.

Notable Publications

Clinical management of patients with systemic lupus erythematosus (SLE) with different C1q-CIC and C3 concentrations 2010 (10)

The Impact of Rituximab Therapy on the Chromosomes of Patients with Rheumatoid Arthritis 2010 (5)

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes 2012 (4)

Sex prediction by geometric morphometric analysis of the hard palate 2022 (2)

Effects of topically applied diclofenac and ketoprofen on Prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (1)